Moving Stocks: QLT Inc. (NASDAQ:QLTI), Cabot Oil & Gas Corporation (NYSE:COG), Orthofix International N.V. (NASDAQ:OFIX), Nektar Therapeutics (NASDAQ:NKTR), Brookfield Property Partners (NYSE:BPY)


QLT Inc. (NASDAQ:QLTI) Director John W. Kozarich acquired 10,000 shares of QLT stock in a transaction dated Monday, December 22nd. The shares were purchased at an average price of $3.59 per share, for a total transaction of $35,900.00. Following the acquisition, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $78,980. QLT Inc. (NASDAQ:QLTI) in last trading activity fell -0.80% to close at $3.73. Company weekly performance is 0.81% while its quarterly performance stands at -20.13%. QLT Inc. (NASDAQ:QLTI) is -47.46% away from its 52 week high.

The Department of Environmental Protection on 2 December has fined Cabot Oil & Gas Corporation (NYSE:COG) of Pittsburgh $120,000 for a January storage tank explosion and production fluid spill at the Reynolds well pad in Jessup Township, Susquehanna County. On last trading day Cabot Oil & Gas Corporation (NYSE:COG) fell -0.07% to close at $29.86. Its volatility for the week is 3.07% while volatility for the month is 4.11%. COG’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was 4.90%. Cabot Oil & Gas Corporation (NYSE:COG) monthly performance is -10.65%.

On last trading day Orthofix International N.V. (NASDAQ:OFIX) fell -0.84% to close at $30.52. Its volatility for the week is 2.20% while volatility for the month is 2.59%. OFIX’s sales growth for past 5 years was -5.10% and its EPS growth for past 5 years was 43.10%. Orthofix International N.V. (NASDAQ:OFIX) monthly performance is 8.07%.

Nektar Therapeutics (NASDAQ:NKTR) CAO Jillian B. Thomsen sold 5,000 shares of the stock on the open market in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $15.56, for a total value of $77,800.00. Following the transaction, the chief accounting officer now directly owns 2,999 shares of the company’s stock, valued at approximately $46,664. Nektar Therapeutics (NASDAQ:NKTR) has 0.36% insider ownership while its institutional ownership stands at 92.90%. In last trading activity company’s stock closed at $15.58.

Brookfield Property Partners LP, (NYSE:BPY) which is bidding for Songbird alongside Qatar Investment Authority, on 9 December said the consortium has received a letter of intention from EMS Capital LP to accept the 350 pence per share offer for the Canary Wharf owner. EMS owns a 3.2% stake. On Monday shares of Brookfield Property Partners L.P. (NYSE:BPY) closed at $23.31.


Leave a Reply

Your email address will not be published. Required fields are marked *